Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02657421 · ClinicalTrials.gov registry record
OLIF25™ /OLIF51™ Study
A clinical trial, sponsored by Medtronic Spinal and Biologics.
- Terminated
- Registry status
- 168
- Enrollment target
NCT02657421 is a clinical trial that was terminated before completion, run by Medtronic Spinal and Biologics. The registered enrollment target is 168 participants.
The verdict
NCT02657421 was terminated before completion, sponsored by Medtronic Spinal and Biologics.
- TERMINATED
- Registry status
- 168 participants
- Enrollment target
Study Summary
The purpose of this single-arm observational study is to observe and document clinical outcomes of the OLIF25™ and OLIF51™ procedures in patients diagnosed with degenerative disc disease or degenerative scoliosis, and report the rate of adverse events of interest through the 24 months follow-up visit.
Interventions
- PROCEDURE Oblique Lateral Interbody Fusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2015-11 |
| Est. Completion | 2018-05-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02657421
The ClinicalTrials.gov registry entry for NCT02657421 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Spinal and Biologics, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oblique Lateral Interbody Fusion is the first listed.
NCT02657421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02657421 about?
NCT02657421 is a clinical study titled "OLIF25™ /OLIF51™ Study". The purpose of this single-arm observational study is to observe and document clinical outcomes of the OLIF25™ and OLIF51™ procedures in patients diagnosed with degenerative disc disease or degenerative scoliosis, and report the rate of adverse events of interest through the 24 months follow-up visi...
What is the current status of trial NCT02657421?
This trial is currently terminated. The enrollment target is 168 participants. The study started on 2015-11. Estimated completion is 2018-05-03.
What interventions are being tested in trial NCT02657421?
The interventions under investigation include: Oblique Lateral Interbody Fusion (PROCEDURE).
Who is sponsoring clinical trial NCT02657421?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.